We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+8.16%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$2.69B
AUM Growth
+$334M
Cap. Flow
+$64.9M
Cap. Flow %
2.42%
Top 10 Hldgs %
22.58%
Holding
272
New
106
Increased
31
Reduced
51
Closed
76

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$63.2M
2
PRGO icon
Perrigo
PRGO
+$59.1M
3
APD icon
Air Products & Chemicals
APD
+$52.1M
4
C icon
Citigroup
C
+$39.7M
5
CYH icon
Community Health Systems
CYH
+$39.4M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$51.2M
2
OC icon
Owens Corning
OC
+$46.4M
3
CF icon
CF Industries
CF
+$45.6M
4
CCK icon
Crown Holdings
CCK
+$44.1M
5
PFE icon
Pfizer
PFE
+$39.6M

Sector Composition

Rank Sector Weight
1 Financials 14.85%
2 Consumer Discretionary 14.19%
3 Healthcare 13.48%
4 Materials 12.25%
5 Consumer Staples 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMT
126
PennyMac Mortgage Investment
PMT
$849M
$4.92M 0.18%
216,709
-64,585
-23% -$1.41M
KMX icon
127
CarMax
KMX
$8.27B
$4.85M 0.18%
+100,000
New +$4.89M
MS icon
128
Morgan Stanley
MS
$337B
$4.8M 0.18%
+178,322
New +$4.78M
GS icon
129
Goldman Sachs
GS
$313B
$4.65M 0.17%
+29,405
New +$4.73M
INGR icon
130
Ingredion
INGR
$6.38B
$4.63M 0.17%
+70,000
New +$4.57M
GPRE icon
131
Green Plains
GPRE
$1.19B
$4.6M 0.17%
+286,907
New +$4.63M
ACOR
132
DELISTED
Acorda Therapeutics
ACOR
$4.58M 0.17%
+1,114
New +$4.8M
MTGE
133
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$4.46M 0.17%
225,572
-1,139,411
-83% -$22M
SLB icon
134
SLB Ltd
SLB
$77.8B
$4.41M 0.16%
49,871
-117
-0.2% -$9.61K
AJG icon
135
Arthur J. Gallagher & Co
AJG
$63.7B
$4.33M 0.16%
99,301
+10,101
+11% +$444K
MDT icon
136
Medtronic
MDT
$107B
$4.25M 0.16%
+79,812
New +$4.29M
FLY
137
DELISTED
Fly Leasing Limited
FLY
$4.25M 0.16%
+306,203
New +$4.31M
CAL icon
138
Caleres
CAL
$396M
$4.21M 0.16%
179,530
+103,277
+135% +$2.4M
RJF icon
139
Raymond James Financial
RJF
$32.5B
$4.2M 0.16%
151,268
-45,033
-23% -$1.3M
AVNR
140
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$4.14M 0.15%
+979,370
New +$4.64M
VAR
141
DELISTED
Varian Medical Systems, Inc.
VAR
$4.1M 0.15%
+62,493
New +$3.96M
AL
142
DELISTED
Air Lease Corp
AL
$4.05M 0.15%
+146,520
New +$4.01M
LLY icon
143
Eli Lilly
LLY
$1.07T
$4.03M 0.15%
80,000
-598,580
-88% -$31.3M
EWJ icon
144
iShares MSCI Japan ETF
EWJ
$21.7B
$4M 0.15%
+84,000
New +$3.89M
DS
145
DELISTED
Drive Shack Inc.
DS
$3.88M 0.14%
763,389
-879,653
-54% -$4.45M
APH icon
146
Amphenol
APH
$188B
$3.87M 0.14%
+400,016
New +$3.91M
CNMD icon
147
CONMED
CNMD
$1.29B
$3.78M 0.14%
+111,219
New +$3.63M
KYTH
148
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$3.77M 0.14%
82,794
-25,707
-24% -$769K
HUB.B
149
DELISTED
HUBBELL INC CL-B
HUB.B
$3.64M 0.14%
+34,757
New +$3.66M
MNTA
150
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.51M 0.13%
243,999
+145,137
+147% +$2.22M

Similar funds

Ascend Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Ascend Capital held 272 positions worth $2.69B, up 14% from $2.35B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital's Q3 2013 filing shows 106 new, 31 increased, 51 reduced and 76 closed positions. Its largest new stake was Altria Group: 1,794,311 shares worth $61.6M. The largest sale was RTX Corp, an estimated $51.2M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Ascend Capital's largest Q3 2013 buy was Altria Group: 1,794,311 shares worth $61.6M.
  • Ascend Capital added most to Citigroup in Q3 2013, an estimated $39.7M increase.
  • Ascend Capital's biggest Q3 2013 reduction was CF Industries, cutting an estimated $45.6M.
  • Ascend Capital fully exited RTX Corp in Q3 2013, selling an estimated $51.2M.
  • Ascend Capital's ten largest holdings make up 23% of its $2.69B portfolio in Q3 2013.
  • Ascend Capital opened 106 new positions and closed 76 in Q3 2013.
  • Ascend Capital's portfolio value rose 14% quarter-over-quarter to $2.69B.

Based on Ascend Capital's 13F filing for Q3 2013, filed 13 Nov 2013.